Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 4, 2012, Pages 1025-1033

  Chen, Shiou Lan ^a,b   Lee, Sheng Yu ^a,b   Tao, Pao Luh ^c   Chang, Yun Hsuan ^a   Chen, Shih Heng ^a,d   Chu, Chun Hsien ^a,d   Chen, Po See ^a,b   Lee, I Hui ^a,b   Yeh, Tzung Lieh ^a,b   Yang, Yen Kuang ^a,b   Hong, Jau Shyong ^d   Lu, Ru Band ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cytokines; Dextromethorphan; Methadone maintenance therapy; Opioid; Plasma

Indexed keywords

DEXTROMETHORPHAN; DIAMORPHINE; INTERLEUKIN 8; METHADONE; MORPHINE; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TOLERANCE; DRUG URINE LEVEL; DRUG USE; FEMALE; HEROIN DEPENDENCE; HUMAN; INFLAMMATION; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STRATIFIED SAMPLE; SUSTAINED DRUG RELEASE; TREATMENT DURATION;

ADULT; AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANALGESICS, OPIOID; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROMETHORPHAN; DOUBLE-BLIND METHOD; FEMALE; HEROIN DEPENDENCE; HUMANS; INFLAMMATION; INTERLEUKIN-8; MALE; METHADONE; MIDDLE AGED; MORPHINE; OPIATE SUBSTITUTION TREATMENT; RECURRENCE; SUBSTANCE ABUSE DETECTION; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84875829064     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9400-1     Document Type: Article

References (55)

1. Allahtavakoli M, Jarrott B (2011) Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in rats. Brain Res Bull 85(3-4):219-24
2. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorder-IV-TR, 4th edn. Washington: American Psychiatric Association
3. Bertolucci M, Perego C, De Simoni MG (1996) Central opiate modulation of peripheral IL-6 in rats. Neuroreport 7:1181-1184
4. Bisaga A, Gianelli P, Popik P (1997) Opiate withdrawal with dextromethorphan. Am J Psychiatry 154:584
5. Bowen WD, Hellewell SB, McGarry KA (1989) Evidence for a multi-site model of the rat brain sigma receptor. Eur J Pharmacol 163:309-318
6. Carter CJ (1982) Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats. Neuropharmacology 21:379-383
7. Chen SL, Huang EY, Chow LH, Tao PL (2005) Dextromethorphan differentially affects opioid antinociception in rats. Br J Pharmacol 144:400-404
8. Chen SL, Hsu KY, Huang EY, Lu RB, Tao PL (2011) Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats. Drug Alcohol Depend 117(2-3):164-9
9. Chen SL, Tao PL, Chu CH, Chen SH, Wu HE, Tseng LF, Hong JS, Lu RB (2012a) Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats. J Neuroimmune Pharmacol 7:444-453
10. Chen SL, Lee SY, Chang YH, Chen SH, Chu CH, Tzeng NS, Lee IH, Chen PS, Yeh TL, Huang SY, Yang YK, Lu RB (2012b) Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan. J Neuroimmune Pharmacol 7(3):656-64
11. Chu NN, Xia W, Yu P, Hu L, Zhang R, Cui CL (2008) Chronic morphine-induced neuronal morphological changes in the ventral tegmental area in rats are reversed by electroacupuncture treatment. Addict Biol 13:47-51
12. Church J, Sawyer D, McLarnon JG (1994) Interactions of dextromethorphan with the N-methyl-D-aspartate receptor-channel complex: single channel recordings. Brain Res 666:189-194
13. Cornish JW, Herman BH, Ehrman RN, Robbins SJ, Childress AR, Bead V, Esmonde CA, Martz K, Poole S, Caruso FS, O'Brien CP (2002) A randomized, double-blind, placebo-controlled safety study of high-dose dextromethorphan in methadone-maintained male inpatients. Drug Alcohol Depend 67:177-183
14. Cunha-Oliveira T, Rego AC, Garrido J, Borges F, Macedo T, Oliveira CR (2010) Neurotoxicity of heroin-cocaine combinations in rat cortical neurons. Toxicology 276:11-17
15. Dyuizen I, Lamash NE (2009) Histo- and immunocytochemical detection of inducible NOS and TNF-alpha in the locus coeruleus of human opiate addicts. J Chem Neuroanat 37:65-70
16. Eisch AJ, Barrot M, Schad CA, Self DW, Nestler EJ (2000) Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci U S A 97:7579-7584
17. Hall AA, Herrera Y, Ajmo CT Jr, Cuevas J, Pennypacker KR (2009) Sigma receptors suppress multiple aspects of microglial activation. Glia 57:744-754
18. Houghtling RA, Bayer BM (2002) Rapid elevation of plasma interleukin-6 by morphine is dependent on autonomic stimulation of adrenal gland. J Pharmacol Exp Ther 300:213-219
19. Huang EY, Liu TC, Tao PL (2003) Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol 368:386-392
20. Huang SY, Lin WW, Ko HC, Lee JF, Wang TJ, Chou YH, Yin SJ, Lu RB (2004) Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res 28:374-384
21. Kapasi AA, Gibbons N, Mattana J, Singhal PC (2000) Morphine stimulates mesangial cell TNF-alpha and nitrite production. Inflammation 24:463-476
22. Koob GF, Nestler EJ (1997) The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 9:482-497
23. Koyuncuoglu H (1991) The treatment with dextromethorphan of heroin addicts. In: Loimer N, Schmid R, Springer A (eds) Drug addiction and AIDS. Springer, Vienna, pp 320-329
24. LaLumiere RT, Kalivas PW (2008) Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci 28:3170-3177
25. Li G, Cui G, Tzeng NS, Wei SJ, Wang T, Block ML, Hong JS (2005) Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage. FASEB J 19:489-496
26. Li MH, Luo YH, Lin CF, Chang YT, Lu SL, Kuo CF, Hong JS, Lin YS (2011) Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group a streptococcal sepsis. Antimicrob Agents Chemother 55:967-973
27. Liu Y, Qin L, Li G, Zhang W, An L, Liu B, Hong JS (2003) Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. J Pharmacol Exp Ther 305:212-218
28. Liu PY, Lin CC, Tsai WC, Li YH, Lin LJ, Shi GY, Hong JS, Chen JH, Wu HL (2008) Treatment with dextromethorphan improves endothelial function, inflammation and oxidative stress in male heavy smokers. J Thromb Haemost 6:1685-1692
29. Lue WM, Huang EY, Yang SN, Wong CS, Tao PL (2007) Post-treatment of dextromethorphan reverses morphine effect on conditioned place preference in rats. Synapse 61:420-428
30. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517-532
31. Massamiri T, Duckles SP (1990) Multiple sites of action of (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine ((+)-3PPP) in blood vessels. Eur J Pharmacol 190:295-303
32. Mintzer MZ, Stitzer ML (2002) Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend 67:41-51
33. Netzer R, Pflimlin P, Trube G (1993) Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons. Eur J Pharmacol 238:209-216
34. Peterson PK, Gekker G, Hu S, Anderson WR, Kravitz F, Portoghese PS, Balfour HH Jr, Chao CC (1994) Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J Neuroimmunol 50:167-175
35. Peterson PK, Molitor TW, Chao CC (1998) The opioid-cytokine connection. J Neuroimmunol 83:63-69
36. Prosser J, London ED, Galynker II (2009) Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging results. Drug Alcohol Depend 104:228-240
37. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55:453-462
38. Raghavendra V, Rutkowski MD, DeLeo JA (2002) The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 22:9980-9989
39. Raghavendra V, Tanga FY, DeLeo JA (2004) Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 29:327-334
40. Robinson TE, Kolb B (1999) Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 33:160-162
41. Ruzicka BB, Fox CA, Thompson RC, Meng F, Watson SJ, Akil H (1995) Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Brain Res Mol Brain Res 34:209-220
42. Shi J, Zhao LY, Copersino ML, Fang YX, Chen Y, Tian J, Deng Y, Shuai Y, Jin J, Lu L (2008) PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol 579:160-166
43. Shin EJ, Nah SY, Chae JS, Bing G, Shin SW, Yen TP, Baek IH, Kim WK, Maurice T, Nabeshima T, Kim HC (2007) Dextromethorphan attenuates trimethyltin-induced neurotoxicity via sigma1 receptor activation in rats. Neurochem Int 50:791-799
44. Simard AR, Rivest S (2005) Do pathogen exposure and innate immunity cause brain diseases? Neurol Res 27:717-725
45. Sklair-Tavron L, Shi WX, Lane SB, Harris HW, Bunney BS, Nestler EJ (1996) Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A 93:11202-11207
46. Su TP (1982) Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther 223:284-290
47. Wang Y, Li W, Li Q, Yang W, Zhu J, Wang W (2011) White matter impairment in heroin addicts undergoing methadone maintenance treatment and prolonged abstinence: a preliminary DTI study. Neurosci Lett 494:49-53
48. Wolfe SA Jr, Kulsakdinun C, Battaglia G, Jaffe JH, De Souza EB (1988) Initial identification and characterization of sigma receptors on human peripheral blood leukocytes. J Pharmacol Exp Ther 247:1114-1119
49. Wolfe SA Jr, Culp SG, De Souza EB (1989) Sigma-receptors in endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary. Endocrinology 124:1160-1172
50. Yang HH, Hou CC, Lin MT, Chang CP (2012) Attenuating heat-induced acute lung inflammation and injury by dextromethorphan in rats. Am J Respir Cell Mol Biol 46:407-413
51. Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Hong JS, Liu B (2004) Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J 18:589-591
52. Zhang W, Qin L, Wang T, Wei SJ, Gao HM, Liu J, Wilson B, Liu B, Kim HC, Hong JS (2005) 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. FASEB J 19:395-397
53. Zhang W, Shin EJ, Wang T, Lee PH, Pang H, Wie MB, Kim WK, Kim SJ, Huang WH, Wang Y, Hong JS, Kim HC (2006) 3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro. FASEB J 20:2496-2511
54. Zin CS, Nissen LM, O'Callaghan JP, Moore BJ, Smith MT (2010) Preliminary study of the plasma and cerebrospinal fluid concentrations of IL-6 and IL-10 in patients with chronic pain receiving intrathecal opioid infusions by chronically implanted pump for pain management. Pain Med (Malden, Mass) 11(4):550-61
55. Zubelewicz B, Muc-Wierzgon M, Harbuz MS, Brodziak A (2000) Central single and chronic administration of morphine stimulates corticosterone and interleukin (IL)-6 in adjuvant-induced arthritis. J Physiol Pharmacol 51:897-906